SPIA
VKTX icon

Steward Partners Investment Advisory’s Viking Therapeutics VKTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Buy
351,178
+12,932
+4% +$418K 0.07% 275
2026
Q1 		$11M Buy
338,246
+21,995
+7% +$707K 0.06% 309
2025
Q4 		$11.1M Buy
316,251
+8,021
+3% +$284K 0.06% 273
2025
Q3 		$8.1M Buy
308,230
+37,821
+14% +$1.13M 0.05% 338
2025
Q2 		$7.17M Buy
270,409
+32,374
+14% +$852K 0.06% 334
2025
Q1 		$5.75M Buy
238,035
+13,626
+6% +$431K 0.05% 355
2024
Q4 		$9.03M Buy
224,409
+66,358
+42% +$3.78M 0.08% 240
2024
Q3 		$10M Buy
158,051
+28,128
+22% +$1.65M 0.09% 216
2024
Q2 		$6.89M Buy
129,923
+45,650
+54% +$2.99M 0.07% 272
2024
Q1 		$6.91M Buy
84,273
+45,527
+118% +$2.03M 0.08% 268
2023
Q4 		$721K Buy
38,746
+21,246
+121% +$278K 0.01% 844
2023
Q3 		$194K Buy
17,500
+7,000
+67% +$100K ﹤0.01% 1299
2023
Q2 		$170K Hold
10,500
– – ﹤0.01% 1361
2023
Q1 		$175K Hold
10,500
– – ﹤0.01% 1349
2022
Q4 		$98.7K Buy
10,500
+10,000
+2,000% +$44.6K ﹤0.01% 1558
2022
Q3 		$1K Buy
+500
New +$1.64K ﹤0.01% 3178
2021
Q2 		– Sell
-6,200
Closed -$39.2K – 7423
2021
Q1 		$39.2K Buy
+6,200
New +$43.6K ﹤0.01% 2109
2020
Q1 		– Sell
-550
Closed -$4K – 2710
2019
Q4 		$4K Buy
550
+250
+83% +$1.82K ﹤0.01% 2318
2019
Q3 		$2K Sell
300
-800
-73% -$5.94K ﹤0.01% 2461
2019
Q2 		$9K Buy
+1,100
New +$9.4K ﹤0.01% 2042
2018
Q4 		– Sell
-300
Closed -$5K – 2109
2018
Q3 		$5K Buy
+300
New +$3.57K ﹤0.01% 2144

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Steward Partners Investment Advisory's VKTX Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Viking Therapeutics (VKTX) stake by 3.8% in Q2 2026, buying an estimated $418K and bringing the position to 351,178 shares worth $13.7M. The position accounts for 0.07% of the portfolio, ranked #275.

Steward Partners Investment Advisory first reported a position in VKTX in Q3 2018 and has held it in 21 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Steward Partners Investment Advisory held 351,178 shares of Viking Therapeutics worth $13.7M as of Q2 2026.
  • Steward Partners Investment Advisory bought 12,932 Viking Therapeutics shares in Q2 2026, an estimated $418K.
  • Viking Therapeutics made up 0.07% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #275 holding.
  • Steward Partners Investment Advisory first reported a position in Viking Therapeutics in Q3 2018 and has held it in 21 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.